Federal Supply Schedule 36F79721D0128

Award Date 3/15/21
Last Date to Order 3/14/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The federal contract indefinite delivery vehicle (IDV) is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Therapeuticsmd, Inc. for the provision of pharmaceuticals, drugs, and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. This multiple-award contract has a potential value of $250,000.00 and a period of performance from May 15, 2020 to May 15, 2024. Therapeuticsmd, Inc.,...
The federal contract indefinite delivery vehicle (IDV) is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Endo USA, Inc. for the provision of pharmaceuticals, drugs, and hematology-related products. The contract, valued at $264 million, is a multiple-award vehicle under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, with a period of performance extending to September 2025. This IDV allows the VA's Veterans Integrated Service Network 12...
The federal contract indefinite delivery vehicle (IDV) award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule. The prime contractor, Gold Coast Medical Supply LP, has been awarded this multiple-award contract by the Veterans Integrated Service Network 12 (VISN 12), which is a part of the Department of Veterans Affairs (VA) - Veterans Health Administration (VHA). The contract, valued at a ceiling of $7,400,000.00, is for the procurement of...
The federal contract Indefinite Delivery Vehicle (IDV) is a Multiple Award Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) for Pharmaceuticals and Drugs, valued at $960,000 and effective through April 30, 2026. The prime contractor is Nationwide Pharmaceutical LLC, doing business as Medical Wholesale, a veteran-owned and service-disabled veteran-owned small business located in San Antonio, Texas. The contract allows Nationwide Pharmaceutical to provide a...
The federal contract indefinite delivery vehicle (IDV) is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Avyxa Pharma, LLC. The contract has a ceiling value of $250,000.00 and a period of performance from May 15, 2025 to May 14, 2030. The FSS contract is for DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS (FSC 65 I B) and will allow the VA to procure these products from Avyxa Pharma, LLC as needed. The contract is a multiple award...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Alvogen, Inc., a for-profit manufacturer of pharmaceutical and healthcare products. The contract, valued at $32,885,990.00, is for the provision of pharmaceuticals, drugs, and hematology-related products (FSS-61-IB) to the VA and other federal agencies. The contract has an ultimate completion date of September 1, 2025 and was originally awarded on April 15, 2017. It is...
The federal contract indefinite delivery vehicle (IDV) is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs to Sanofi-Aventis U.S. LLC, a foreign-owned for-profit pharmaceutical company. The FSS contract, which has a ceiling value of $4,958,982,930 and a period of performance through May 31, 2028, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract also includes a single-award Blanket Purchase Agreement (BPA) with a...
The federal contract indefinite delivery vehicle (IDV) awarded by the U.S. Department of Veterans Affairs (VA) to Covis Pharmaceuticals, Inc. is a Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract has a total ceiling value of $1,132,470.00 and a period of performance from July 1, 2017 to June 30, 2025. The purpose of this contract is to provide the VA with a range of pharmaceutical and hematology-related products. As a multiple award FSS contract,...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Nobelpharma America, LLC, a foreign-owned, self-certified small disadvantaged business. The FSS contract, under Federal Supply Class 65 I B, provides for the delivery of pharmaceutical and hematology-related products to VA facilities nationwide, with a ceiling value of $225,000 and a period of performance through May 2028. Additionally, Nobelpharma America, LLC was awarded a...

The federal contract indefinite delivery vehicle (IDV) in question is a 5-year, $1.3 million Federal Supply Schedule contract awarded in March 2021 by the Department of Veterans Affairs (VA) to Beutlich Pharmaceuticals, LLC, a self-certified small disadvantaged business. The contract is under GSA's Pharmaceutical and Drugs schedule (FSS-61-IB) and authorizes the prime contractor to provide pharmaceuticals, drugs, and hematology-related products to support VA healthcare services for veterans.

As a multiple award schedule, this IDV facilitates the issuance of delivery orders for various prescription medications and medical supplies. To date, two delivery orders totaling $12,419.55 have been awarded for "OTHER MEDICAL" supplies. The contract has a period of performance through March 2026 and does not utilize any set-asides. Beutlich Pharmaceuticals, LLC also holds a separate $2.3 million single award IDC from the Defense Logistics Agency to manufacture and distribute medical products through October 2031.

Generated 2/28/25, 9:49 AM